Ledger.Open graph →
SEC Form D · filed July 25, 2018

WINDTREE THERAPEUTICS INC /DE/

Offering
$1.5M
Sold
$1.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WARRINGTON, PA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Graves Tompkins · New York, NYExecHarold C. Nash · Luxembourg, LuxembourgDirectorMark Dzialga · Greenwich, CTExecChristy A. Shaffer · RESEARCH TRIANGLE PARK, NCDirectorAndrew Pearson · Greenwich, CTExecMark A. Velleca · RESEARCH TRIANGLE PARK, NCExecRob W. Holland · Greenwood Village, COExecAndrew G. Crawford · New York, NYExec · DirectorMichelle Dipp · New York, NYDirectorGregory N. Mossinghoff · RESEARCH TRIANGLE PARK, NCExec · DirectorJoseph Hardiman · Grand Cayman, Cayman IslandsExecDonald L. Dillingham · Oklahoma City, OKExec · DirectorDaniel H. Weintraub · Boston, MADirectorRichard Mott · Redwood City, CADirectorPeter Trovato · Quincy, MAExecAlister W. Reynolds · Boulder, COExec · DirectorMatthew W. Norkunas · Boulder, COExecTakayuki W. Shiratsuchi · Boulder, CODirectorTerry W. Randall · Boulder, COExecLarry Gold · Boulder, COExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗